natgillin/translations-raw huggingface dataset:
A decrease in the capital of the AIF in connection with distributions according to the rules or instruments of incorporation of the AIF, its prospectus or offering documents, including one that has been authorised by a resolution of the shareholders or unitholders passed in accordance with those rules or instruments of incorporation, prospectus or offering documents, shall not be taken into account for the purpose of determining whether or not the AIF is of the open-ended type.
Zmanjšanje kapitala AIS v povezavi z razdelitvami v skladu s pravili ali akti o ustanovitvi AIS, njegovim prospektom ali ponudbenimi dokumenti, vključno z zmanjšanjem, ki je bilo odobreno s sklepom delničarjev ali imetnikov enot premoženja, sprejetim v skladu z navedenimi pravili ali akti o ustanovitvi, prospektom ali ponudbenimi dokumenti, se ne bi smelo upoštevati pri določanju, ali je AIS odprtega tipa ali ne.
Whether an AIF's shares or units can be negotiated on the secondary market and are not repurchased or redeemed by the AIF shall not be taken into account for the purpose of determining whether or not the AIF is of the open-ended type.
V primeru, da se lahko z delnicami ali enotami premoženja AIS trguje na sekundarnem trgu in jih AIS ne odkupi ponovno oziroma izplača, se to pri določanju, ali je AIS odprtega ali zaprtega tipa, ne upošteva.
An AIFM of a closed-ended AIF shall be an AIFM which manages an AIF other than of the type described in paragraph 2.
UAIS za AIS zaprtega tipa je UAIS, ki upravlja AIS, ki ni tipa, opisanega v odstavku 2.
Where a change in the redemption policy of the AIF has the effect of changing the type of AIF(s) an AIFM manages, the rules relevant to the new type of AIF shall be applied to that AIF by the AIFM.
Kadar sprememba politike glede izplačil in odkupa AIS privede do spremembe vrste AIS, ki ga upravlja UAIS, ta za navedeni AIS uporablja pravila, ki veljajo za novi tip AIS.
For the purposes of Article 61(3) and (4) of Directive 2011/61/EU, an AIFM in so far as it manages AIFs whose shares or units are, at the request of any of its shareholders or unitholders, repurchased or redeemed prior to the commencement of its liquidation phase or wind-down, directly or indirectly, out of the assets of the AIFs after an initial period of at least 5 years during which redemption rights are not exercisable shall also be considered to be an AIFM of a closed-ended AIF.
Za namene člena 61(3) in (4) Direktive 2011/61/EU se UAIS, ki upravlja AIS, katerega delnice ali enote premoženja se na zahtevo katerega koli delničarja ali imetnika enot premoženja ponovno odkupijo ali izplačajo, preden se je začela faza likvidacije ali prenehanja, posredno ali neposredno, iz sredstev AIS po začetnem obdobju vsaj petih let, v katerem odkupne pravice niso izvršljive, prav tako šteje kot UAIS za AIS zaprtega tipa.
OJ L 174, 1.7.2011, p. 1.
UL L 174, 1.7.2011, str. 1.
Regulation (EU) No 1095/2010 of the European Parliament and of the Council of 24 November 2010 establishing a European Supervisory Authority (European Securities and Markets Authority), amending Decision No 716/2009/EC and repealing Commission Decision 2009/77/EC (OJ L 331, 15.12.2010, p.
Uredba (EU) št. 1095/2010 Evropskega parlamenta in Sveta z dne 24. novembra 2010 o ustanovitvi Evropskega nadzornega organa (Evropski organ za vrednostne papirje in trge) in o spremembi Sklepa št. 716/2009/ES ter razveljavitvi Sklepa Komisije 2009/77/ES (UL L 331, 15.12.2010, str.
Commission Implementing Regulation (EU) No 695/2014
Izvedbena uredba Komisije (EU) št. 695/2014
Done at Brussels, 23 June 2014.
V Bruslju, 23. junija 2014
Commission Regulation (EU) No 696/2014
Uredba Komisije (EU) št. 696/2014
amending Regulation (EC) No 1881/2006 as regards maximum levels of erucic acid in vegetable oils and fats and foods containing vegetable oils and fats
o spremembi Uredbe (ES) št. 1881/2006 glede mejnih vrednosti eruka kisline v rastlinskih oljih in masteh ter v živilih, ki vsebujejo rastlinska olja in masti
Commission Regulation (EC) No 1881/2006 [2] sets maximum levels for contaminants in food.
Uredba Komisije (ES) št. 1881/2006 [2] določa mejne vrednosti onesnaževal v živilih.
A maximum level for erucic acid in oils and fats intended as such for human consumption and in foodstuffs containing added oils and fats has been established by Council Directive 76/621/EEC [3].
Mejna vrednost eruka kisline v oljih in masteh, namenjenih prehrani ljudi, ter v živilih, ki so jim dodana olja in masti, je bila določena z Direktivo Sveta 76/621/EGS [3].
Erucic acid is a natural plant toxin which is a contaminant according to the definition of the contaminant provided in Regulation (EEC) No 315/93 as the presence of erucic acid in food is the result of the agricultural production, more in particular the choice of the variety.
Eruka kislina je naravni rastlinski toksin, ki je onesnaževalo v skladu z opredelitvijo onesnaževala iz Uredbe (EGS) št. 315/93, saj je prisotnost eruka kisline v hrani posledica kmetijske proizvodnje, in sicer izbire sorte.
To simplify the legislation, it is appropriate to establish the maximum level for erucic acid in Regulation (EC) No 1881/2006.
Za poenostavitev zakonodaje je primerno določiti mejno vrednost eruka kisline v Uredbi (ES) št. 1881/2006.
Furthermore it is appropriate to harmonise the provisions for foodstuffs with a fat content equal or less than 5 %.
Prav tako je primerno uskladiti določbe za živila z vsebnostjo maščobe 5 % ali manj.
Directive 76/621/EEC shall then be repealed subsequently by a self-standing legal act.
Direktiva 76/621/EGS se nato razveljavi s samostojnim pravnim aktom.
The appropriateness of a maximum level for erucic acid has been highlighted by the Scientific Committee on Food in its opinion expressed on 17 September 1993 on essential requirements for infant formulae and follow-on formulae [4].
Ustreznost mejne vrednosti eruka kisline je bila izpostavljena v mnenju Znanstvenega odbora za hrano z dne 17. septembra 1993 o bistvenih zahtevah za proizvodnjo začetnih formul za dojenčke in nadaljevalnih formul za dojenčke in majhne otroke [4].
A stricter maximum level for erucic acid in infant formulae and follow-on formulae has been established by Commission Directive 2006/141/EC [5]; it is appropriate to indicate this maximum level also in Regulation (EC) No 1881/2006.
Z Direktivo Komisije 2006/141/ES [5] je bila določena strožja mejna vrednost za eruka kislino v začetnih formulah za dojenčke in nadaljevalnih formulah za dojenčke in majhne otroke, ki jo je primerno navesti tudi v Uredbi (ES) št. 1881/2006.
Regulation (EC) No 1881/2006 should therefore be amended accordingly.
Uredbo (ES) št. 1881/2006 bi bilo treba zato ustrezno spremeniti.
In the Annex to Regulation (EC) No 1881/2006, the following Section 8 ‘Inherent plant toxins’ is added.
V Prilogi k Uredbi (ES) št. 1881/2006 se doda naslednji oddelek 8 „Vsebovani rastlinski toksini“.
‘Section 8: Inherent plant toxins
„Oddelek 8: Vsebovani rastlinski toksini
Maximum levels (g/kg)
Mejne vrednosti (g/kg)
Erucic acid
eruka kislina
Foods containing added vegetable oils and fats with the exception of the foods referred to in 8.1.3
živila, ki vsebujejo dodana rastlinska olja in masti, razen živil iz točke 8.1.3
Infant formulae and follow-on formulae (8)
začetne formule za dojenčke in nadaljevalne formule za dojenčke in majhne otroke (8)
OJ L 37, 13.2.1993, p. 1.
UL L 37, 13.2.1993, str. 1.
Council Directive 76/621/EEC of 20 July 1976 relating to the fixing of the maximum level of erucic acid in oils and fats intended as such for human consumption and in foodstuffs containing added oils and fats (OJ L 202, 28.7.1976, p. 35).
Direktiva Sveta 76/621/EGS z dne 20. julija 1976 o določitvi zgornje mejne vrednosti eruka kisline v oljih in masteh, namenjenih prehrani ljudi, ter v živilih, ki so jim dodana olja in masti (UL L 202, 28.7.1976, str. 35).
Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999/21/EC (OJ L 401, 30.12.2006, p. 1).
Direktiva Komisije 2006/141/ES z dne 22. decembra 2006 o začetnih formulah za dojenčke in nadaljevalnih formulah za dojenčke in majhne otroke in o spremembi Direktive 1999/21/ES (UL L 401, 30.12.2006, str. 1).
the maximum level refers to the level of erucic acid, calculated on the total level of fatty acids in the fat component in food.’
Mejna vrednost se nanaša na vsebnost eruka kisline, izračunano glede na skupno vsebnost maščobnih kislin v maščobni komponenti hrane.“
Commission Regulation (EU) No 697/2014
Uredba Komisije (EU) št. 697/2014
amending Regulation (EC) No 906/2009 as regards its period of application
o spremembi Uredbe (ES) št. 906/2009 glede njenega obdobja uporabe
Having regard to Council Regulation (EC) No 246/2009 of 26 February 2009 on the application of Article 81(3) of the Treaty to certain categories of agreements, decisions and concerted practices between liner shipping companies (consortia) [1], and in particular Article 1 thereof,
ob upoštevanju Uredbe Sveta (ES) št. 246/2009 z dne 26. februarja 2009 o uporabi člena 81(3) Pogodbe za nekatere skupine sporazumov, sklepov in usklajenih ravnanj med prevozniki v linijskem prevozu po morju (konzorciji) [1], in zlasti člena 1 Uredbe,
Commission Regulation (EC) No 906/2009 [2] grants a block exemption to liner shipping consortia from the prohibition contained in Article 101(1) of the Treaty, subject to certain conditions.
Uredba Komisije (ES) št. 906/2009 [2] konzorcijem družb za prevozne storitve po morju pod nekaterimi pogoji omogoča skupinsko izjemo pri prepovedi iz člena 101(1) Pogodbe.
That Regulation will expire on 25 April 2015, in accordance with the maximum 5-year duration provided for in Article 2(1) of Regulation (EC) No 246/2009.
Navedena uredba bo prenehala veljati 25. aprila 2015, skladno z najdaljšo dovoljeno veljavnostjo 5 let, ki je določena v členu 2(1) Uredbe (ES) št. 246/2009.
On the basis of the Commission's experience in applying the block exemption, it appears that the justifications for a block exemption for consortia are still valid and that the conditions on the basis of which the scope and content of Regulation (EC) No 906/2009 were determined have not substantially changed.
Na podlagi izkušenj Komisije pri uporabi skupinske izjeme se zdi, da je utemeljitev za skupinsko izjemo pri konzorcijih še vedno veljavna in da se pogoji, na osnovi katerih sta se določila področje uporabe in vsebina Uredbe (ES) št. 906/2009, niso bistveno spremenili.
Regulation (EC) No 906/2009 simplified and introduced substantial modifications to the rules applicable to consortia.
Uredba (ES) št. 906/2009 je poenostavila in uvedla pomembne spremembe pravil, ki se uporabljajo za konzorcije.
Since the new legal framework has been in place and applied for only a short period of time, further changes should be avoided at this stage.
Ker je nov pravni okvir vzpostavljen in se uporablja šele kratek čas, bi se bilo treba izogibati nadaljnjim spremembam.
This will avoid increasing the compliance costs of the operators in the industry.
To bo preprečilo povečanje stroškov zagotavljanja skladnosti za gospodarske subjekte v sektorju.
The period of application of Regulation (EC) No 906/2009 should therefore be extended by five years,
Obdobje uporabe Uredbe (ES) št. 906/2009 bi se zato moralo podaljšati za pet let –
In Article 7 of Regulation (EC) No 906/2009 ‘25 April 2015’ is replaced by ‘25 April 2020’.
V členu 7 Uredbe (ES) št. 906/2009 se datum „25. aprila 2015“ nadomesti s „25. aprila 2020“.
It shall apply from 25 April 2015.
Uporablja se od 25. aprila 2015.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Ta uredba v je celoti zavezujoča in se neposredno uporablja v vseh državah članicah.
OJ L 79, 25.3.2009, p. 1.
UL L 79, 25.3.2009, str. 1.
With effect from 1 December 2009, Articles 81 and 82 of the EC Treaty have become respectively Articles 101 and 102 TFEU.
Z učinkom od 1. decembra 2009 sta člena 81 in 82 Pogodbe ES postala člen 101 oziroma 102 PDEU.
Commission Regulation (EC) No 906/2009 of 28 September 2009 on the application of Article 81(3) of the Treaty to certain categories of agreements, decisions and concerted practices between liner shipping companies (consortia) (OJ L 256, 29.9.2009, p. 31).
Uredba Komisije (ES) št. 906/2009 z dne 28. septembra 2009 o uporabi člena 81(3) Pogodbe za nekatere skupine sporazumov, sklepov in usklajenih ravnanj med prevozniki v linijskem prevozu po morju (konzorciji) (UL L 256, 29.9.2009, str. 31).
Commission Implementing Regulation (EU) No 698/2014
Izvedbena uredba Komisije (EU) št. 698/2014
amending Regulation (EC) No 2076/2002 as regards delta-endotoxin of Bacillus thuringiensis
o spremembi Uredbe (ES) št. 2076/2002 glede delta-endotoksina bakterije Bacillus thuringiensis
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular Article 78(2) thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS [1] ter zlasti člena 78(2) Uredbe,
Commission Regulation (EC) No 2076/2002 [2] listed delta-endotoxin of Bacillus thuringiensis in its Annex I setting out active substances which are not included as active substance in Annex I to Council Directive 91/414/EEC [3].
Z Uredbo Komisije (ES) št. 2076/2002 [2] je bil delta-endotoksin bakterije Bacillus thuringiensis uvrščen v Prilogo I, ki vsebuje seznam aktivnih snovi, ki niso vključene kot aktivne snovi v Prilogo I k Direktivi Sveta 91/414/EGS [3].
That listing was due to the fact that a commitment to further prepare the necessary dossier for that active substance had not been notified.
Navedena uvrstitev je bila posledica dejstva, da pripravljenost za nadaljnjo pripravo potrebne dokumentacije za navedeno aktivno snov ni bila sporočena.
The Commission realised that listing delta-endotoxin of Bacillus thuringiensis in Annex I to Regulation (EC) No 2076/2002 could give rise to confusion in view of the fact that Commission Implementing Regulation (EU) No 540/2011 [4] lists several strains of Bacillus thuringiensis as approved active substances.
Komisija je ugotovila, da bi lahko uvrstitev delta-endotoksina bakterije Bacillus thuringiensis v Prilogo I k Uredbi (ES) št. 2076/2002 povzročila zmedo, saj so številni sevi bakterije Bacillus thuringiensis v Izvedbeni uredbi Komisije (EU) št. 540/2011 [4] navedeni kot odobrene aktivne snovi.
Annex I to Regulation (EC) No 2076/2002 should therefore be amended accordingly.
Prilogo I k Uredbi (ES) št. 2076/2002 bi bilo zato treba ustrezno spremeniti –
Amendment to Regulation (EC) No 2076/2002
Sprememba Uredbe (ES) št. 2076/2002
In Annex I to Regulation (EC) No 2076/2002 the entry ‘delta-endotoxin of Bacillus thuringiensis’ is deleted.
V Prilogi I k Uredbi (ES) št. 2076/2002 se vnos „delta-endotoksin bakterije Bacillus thuringiensis“ črta.
Commission Regulation (EC) No 2076/2002 of 20 November 2002 extending the time period referred to in Article 8(2) of Council Directive 91/414/EEC and concerning the non-inclusion of certain active substances in Annex I to that Directive and the withdrawal of authorisations for plant protection products containing these substances (OJ L 319, 23.11.2002, p. 3).
Uredba Komisije (ES) št. 2076/2002 z dne 20. novembra 2002 o podaljšanju roka iz člena 8(2) Direktive Sveta 91/414/EGS in o nevključitvi nekaterih aktivnih snovi v Prilogo I k navedeni direktivi ter o odvzemu registracij za fitofarmacevtska sredstva, ki vsebujejo te snovi (UL L 319, 23.11.2002, str. 3).
Commission Implementing Regulation (EU) No 699/2014
Izvedbena uredba Komisije (EU) št. 699/2014
on the design of the common logo to identify persons offering medicinal products for sale at a distance to the public and the technical, electronic and cryptographic requirements for verification of its authenticity
o zasnovi skupnega logotipa za identifikacijo oseb, ki ponujajo zdravila v prodajo javnosti na daljavo, ter o tehničnih, elektronskih in kriptografskih zahtevah za preverjanje avtentičnosti
Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to medicinal products for human use [1], and in particular Article 85c(3) thereof,
ob upoštevanju Direktive 2001/83/ES Evropskega parlamenta in Sveta z dne 6. novembra 2001 o zakoniku Skupnosti o zdravilih za uporabo v humani medicini [1] in zlasti člena 85c(3) Direktive,
Article 85c(3) of Directive 2001/83/EC provides that a common logo recognisable throughout the Union should be established, which will enable the identification of the Member State where the person offering medicinal products for sale at a distance to the public by means of information society services is established.
Člen 85c(3) Direktive 2001/83/ES določa, da se oblikuje skupni logotip, prepoznaven po vsej Uniji in ki hkrati omogoča identifikacijo države članice, v kateri ima sedež oseba, ki ponuja zdravila v prodajo javnosti na daljavo prek storitev informacijske družbe.
Pursuant to Article 85c(3)(a) of Directive 2001/83/EC, the Commission should adopt implementing acts in order to harmonise the functioning of common logo regarding the technical, electronic and cryptographic requirements for verification of the authenticity of the common logo.
V skladu s členom 85c(3)(a) Direktive 2001/83/ES bi morala Komisija sprejeti izvedbene akte za uskladitev delovanja skupnega logotipa glede tehničnih, elektronskih in kriptografskih zahtev za preverjanje avtentičnosti skupnega logotipa.
These requirements should provide for a high level of security and prevent any fraudulent use of the logo.
Te zahteve bi morale zagotavljati visoko raven varnosti in preprečujejo goljufivo uporabo logotipa.
In line with Article 85c(1)(d)(iii) the verification of the authenticity of the common logo is done via a hyperlink between the logo and the entry of the person authorised or entitled to offer medicinal products for sale at a distance to the public by means of information society services on the list referred to in Article 85c(4)(c).
V skladu s členom 85c(1)(d)(iii) preverjanje avtentičnosti skupnega logotipa poteka prek hiperpovezave med logotipom in vnosom osebe, ki ima dovoljenje ali pravico, da ponuja zdravila v prodajo javnosti na daljavo prek storitev informacijske družbe, in je navedena na seznamu iz člena 85c(4)(c).
Therefore, these hyperlinks should be permanent and secured.
Zato bi morale biti te hiperpovezave trajne in varovane.
In order to prevent a fraudulent use of the logo, the national websites referred to Article 85c(4) should be secured, updated and hosted on trusted domains.
Za preprečitev goljufive uporabe logotipa bi morala biti nacionalna spletna mesta iz člena 85c(4) varovana in posodobljena ter bi morala gostovati na zanesljivih domenah.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,
Ukrepi iz te uredbe so v skladu z mnenjem Stalnega odbora za zdravila za uporabo v humani medicini –
The design of the common logo referred to in Article 85c(3)(b) of Directive 2001/83/EC shall follow the model set out in the Annex to this Regulation.
Zasnova skupnega logotipa iz člena 85c(3)(b) Direktive 2001/83/ES je v skladu z vzorcem iz Priloge k tej uredbi.
The website, mentioned in Article 85c(4) shall be accessible in such a way that the public can be easily assured that it is the trusted site for the purpose.
Spletno mesto iz člena 85c(4) je dostopno tako, da je mogoče javnosti brez težav zagotoviti, da je zanesljivo za ta namen.
The hyperlink, mentioned in Article 85c(1)(d)(iii) of Directive 2001/83/EC between the website of the person authorised or entitled to supply medicinal products at a distance to the public by means of information society services and the website hosting the national list mentioned in Article 85c(4)(c) of the Directive, shall be fixed and reciprocal.
Hiperpovezava iz člena 85c(1)(d)(iii) Direktive 2001/83/ES med spletnim mestom osebe, ki ima dovoljenje ali pravico, da ponuja zdravila v prodajo javnosti na daljavo prek storitev informacijske družbe, in spletnim mestom, ki gosti nacionalni seznam iz člena 85c(4)(c) Direktive, je fiksna in vzajemna.
The information transit between the websites authorised or entitled to supply medicinal products at a distance to the public by means of information society services and the websites hosting the national lists shall be secured through appropriate means.
Pretok informacij med spletnimi mesti, odobrenimi ali upravičenimi do ponujanja zdravil v prodajo javnosti na daljavo prek storitev informacijske družbe, in spletnimi mesti, ki gostijo nacionalne sezname, je varovan z ustreznimi sredstvi.
In order for the hyperlink mentioned in the first paragraph of Article 3 to work reliably the websites hosting the national lists set up in accordance with Article 85c(4)(c) of Directive 2001/83/EC shall be secured and updated, with an indication of the latest update moment.
Za zanesljivo delovanje hiperpovezave iz prvega odstavka člena 3 so spletna mesta, ki gostijo nacionalne sezname, vzpostavljene v skladu s členom 85c(4)(c) Direktive 2001/83/ES, varna, posodobljena in vključujejo navedbo zadnje posodobitve.
It shall apply as from 1 July 2015.
Uporablja se od 1. julija 2015.
The model referred to in Article 1 for the common logo is the following:
Vzorec skupnega logotipa iz člena 1 je naslednji:
The reference colours are: PANTONE 421 CMYK 13/11/8/26 RGB 204/204/204; PANTONE 7731 CMYK 79/0/89/22 RGB 0/153/51; PANTONE 376 CMYK 54/0/100/0 RGB 153/204/51; PANTONE 7480 CMYK 75/0/71/0.
Referenčne barve so: PANTONE 421 CMYK 13/11/8/26 RGB 204/204/204; PANTONE 7731 CMYK 79/0/89/22 RGB 0/153/ 51; PANTONE 376 CMYK 54/0/100/0 RGB 153/204/51; PANTONE 7480 CMYK 75/0/71/0.
The national flag of the Member State where the natural or legal person supplying medicinal products to the public at a distance by means of information society services is established shall be inserted in the white rectangle in the middle (left side) of the common logo.
Nacionalna zastava države članice, v kateri ima sedež fizična ali pravna oseba, ki ponuja zdravila javnosti na daljavo prek storitev informacijske družbe, se vstavi v bel pravokotnik v sredini (na levi strani) skupnega logotipa.
The language of the text in the common logo shall be established by the Member State referred to in point 3.
Jezik besedila v skupnem logotipu določi država članica, navedena v točki 3.
The common logo shall have a minimum width size of 90 pixel.
Skupni logotip je širok najmanj 90 točk.
The common logo shall be static.
Skupni logotip je statičen.
If the logo is used on a coloured background which makes it difficult to see, a delimiting outer line around the logo can be used to improve contrast with the background colour.
Če se logotip uporablja na barvnem ozadju, zaradi česar je težko viden, se lahko uporabi razmejevalni rob okrog logotipa, da se izboljša kontrast z barvnim ozadjem.
Commission Regulation (EU) No 702/2014
Uredba Komisije (EU) št. 702/2014
declaring certain categories of aid in the agricultural and forestry sectors and in rural areas compatible with the internal market in application of Articles 107 and 108 of the Treaty on the Functioning of the European Union
o razglasitvi nekaterih vrst pomoči v kmetijskem in gozdarskem sektorju ter na podeželju za združljive z notranjim trgom z uporabo členov 107 in 108 Pogodbe o delovanju Evropske unije
Having regard to Council Regulation (EC) No 994/98 of 7 May 1998 on the application of Articles 107 and 108 of the Treaty on the Functioning of the European Union to certain categories of horizontal State aid [1] and in particular Article 1(1)(a) and (b) thereof,
ob upoštevanju Uredbe Sveta (ES) št. 994/98 z dne 7. maja 1998 o uporabi členov 107 in 108 Pogodbe o delovanju Evropske unije za določene vrste horizontalne državne pomoči [1] ter zlasti člena 1(1)(a) in (b) Uredbe,